BioMotiv
BioMotiv is an accelerator company associated with The Harrington Project, a national initiative centered at University Hospitals of Cleveland. The company is designed to accelerate breakthrough discoveries into medicines by advancing a portfolio of novel therapeutics in all disease areas and types of therapeutics — small molecules, antibodies, proteins, cell therapies, and nucleotides – from the discovery to pre-clinical stages of development and will also consider drug re-purposing opportunities. Opportunities are sourced primarily through relationships with research institutions and disease foundations.
BioMotiv
BioMotiv is an accelerator company associated with The Harrington Project, a national initiative centered at University Hospitals of Cleveland. The company is designed to accelerate breakthrough discoveries into medicines by advancing a portfolio of novel therapeutics in all disease areas and types of therapeutics — small molecules, antibodies, proteins, cell therapies, and nucleotides – from the discovery to pre-clinical stages of development and will also consider drug re-purposing opportunities. Opportunities are sourced primarily through relationships with research institutions and disease foundations.
has abstract
BioMotiv is an accelerator com ...... tions and disease foundations.
@en
foundation place
founding year
thumbnail
Link from a Wikipage to an external page
Wikipage page ID
42,576,177
Wikipage revision ID
743,405,462
key people
Baiju Shah, CEO
subsid
Dual Therapeutics
Orca Pharmaceuticals
hypernym
comment
BioMotiv is an accelerator com ...... tions and disease foundations.
@en
label
BioMotiv
@en